Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
September 16, 2019
Essential ingredients for rational drug design
Ashley Jarvis, Gilles Ouvry
Expert Review of Anticancer Therapy
|
December 27, 2005
Aurora A and B kinases as targets for cancer: will they be selective for tumors?
Nick Matthews, Cristina Visintin, Basil Hartzoulakis, et al.
Nutrition Reviews
|
October 15, 2013
Principles for building public-private partnerships to benefit food safety, nutrition, and health research
Sylvia Rowe, Nick Alexander, Alison Kretser, et al.
The Journal of Biological Chemistry
|
March 4, 2006
Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling
Haiyan Jia, Azadeh Bagherzadeh, Basil Hartzoulakis, et al.
Chembiochem : a European Journal of Chemical Biology
|
April 29, 2014
N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity
Haiyan Jia, Rehan Aqil, Lili Cheng, et al.
Journal of Medicinal Chemistry
|
February 16, 2010
Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction
Ashley Jarvis, Charles K Allerston, Haiyan Jia, et al.
ACS Pharmacology & Translational Science
|
November 20, 2025
Quinoline-Based Neuropilin‑1 Antagonists Exhibit a Pure Antagonist Profile and Block Vascular Endothelial Growth Factor-Induced Pain
Sara Hestehave, Silvia Dragoni, Philip Fallon, et al.
Journal of Medicinal Chemistry
|
April 13, 2018
Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells
Jonathan Powell, Filipa Mota, David Steadman, et al.
Cell Stem Cell
|
March 12, 2019
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo
Lorna R Fiedler, Kathryn Chapman, Min Xie, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Bioorganic & Medicinal Chemistry Letters
|
September 16, 2019
Essential ingredients for rational drug design
Ashley Jarvis, Gilles Ouvry
Expert Review of Anticancer Therapy
|
December 27, 2005
Aurora A and B kinases as targets for cancer: will they be selective for tumors?
Nick Matthews, Cristina Visintin, Basil Hartzoulakis, et al.
Nutrition Reviews
|
October 15, 2013
Principles for building public-private partnerships to benefit food safety, nutrition, and health research
Sylvia Rowe, Nick Alexander, Alison Kretser, et al.
The Journal of Biological Chemistry
|
March 4, 2006
Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling
Haiyan Jia, Azadeh Bagherzadeh, Basil Hartzoulakis, et al.
Chembiochem : a European Journal of Chemical Biology
|
April 29, 2014
N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity
Haiyan Jia, Rehan Aqil, Lili Cheng, et al.
Journal of Medicinal Chemistry
|
February 16, 2010
Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction
Ashley Jarvis, Charles K Allerston, Haiyan Jia, et al.
ACS Pharmacology & Translational Science
|
November 20, 2025
Quinoline-Based Neuropilin‑1 Antagonists Exhibit a Pure Antagonist Profile and Block Vascular Endothelial Growth Factor-Induced Pain
Sara Hestehave, Silvia Dragoni, Philip Fallon, et al.
Journal of Medicinal Chemistry
|
April 13, 2018
Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells
Jonathan Powell, Filipa Mota, David Steadman, et al.
Cell Stem Cell
|
March 12, 2019
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo
Lorna R Fiedler, Kathryn Chapman, Min Xie, et al.
Page
of 1